(31 Aug 2020) Interferons- IFN β-1b significantly increased the discharge rate at day 14
Interferon beta-1b in treatment of severe COVID-19: A randomized clinical trial https://doi.org/10.1016/j.intimp.2020.106903 In this study (IRCT20100228003449N27), efficacy and safety of interferon (IFN) beta-1b in the treatment of patients with severe COVID-19 were evaluated. The primary outcome of the study was… Continue reading "(31 Aug 2020) Interferons- IFN β-1b significantly increased the discharge rate at day 14"